EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: FINAL RESULTS FROM THE PHASE 3 U-ENDURE STUDY

Miguel Regueiro  ¹     Scott Lee  ²     Raja Atreya  ³     Efrat Broide  ⁴     Cristina Rodriguez  ⁵     Adriaan A. Van Bodegraven  ⁶     Elena Dubcenco  ⁷     Ana Paula Machado De Lacerda  ⁷     Jianzhong Liu  ⁷     Tian Feng  ⁷     Ziqian Geng  ⁷     Valencia Remple  ⁷     Samuel Anyanwu  ⁷     Julian Panés  ^8    
1 Cleveland Clinic, Cleveland, United States
² University of Washington Medical Center, Seattle, United States
³ Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
⁴ The Kamila Gonczarowski Institute of Gastroenterology and Liver Diseases, Assaf Harofeh Medical Center, Zerifin, Israel
⁵ University Hospital of Navarra, Pamplona, Spain
⁶ Zuyderland Medical Center, Herleen, Sittard-Geleen, Netherlands
⁷ AbbVie Inc., North Chicago, United States
⁸ Hospital Clinic Barcelona, IDIPABS, CIBERehd, Barcelona, Spain

Topic
IBD

Session
Hit the road JAK: Part 2

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)